ReviewKidney diseases (Basel, Switzerland)2023

Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.